IL-31 Rabbit Polyclonal Antibody
IL-31 Rabbit Polyclonal Antibody
IL-31 Polyclonal Antibody |
|||
ABP57596-02ml | Abbkine | 0.2ml | 414 EUR |
Description: A polyclonal antibody for detection of IL-31 from Human. This IL-31 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthetic peptide from human protein at AA range: 21-70 |
|||
XMIR-31 RNA oligo miRNA-31-5p with Xmotif |
|||
XMIR-31 | SBI | 10 rxn | 438 EUR |
IL-31 Antibody |
|||
24390-100ul | SAB | 100ul | 390 EUR |
IL-31 Antibody |
|||
24391-100ul | SAB | 100ul | 390 EUR |
IL-31 Antibody |
|||
3745-002mg | ProSci | 0.02 mg | 171.82 EUR |
Description: IL-31 Antibody: Interleukin-31 (IL-31) is a recently discovered T-cell cytokine closely related to IL-6 type cytokines and is preferentially produced by T helper type 2 cells. IL-31 activity is mediated through the ligand-induced oligomerization of a dimeric receptor complex containing IL-31 receptor A and oncostatin M receptor. In response to IL-31 binding, these proteins activate the JAK/STAT and the AKT signaling pathways. RNA levels of IL-31 receptor A and oncostatin M receptor are induced in activated monocytes but are expressed constitutively in epithelial cells. IL-31, when overexpressed in transgenic mice, results in the development of pruritis, alopecia, and skin lesions and in humans may result in atopic dermatitis, suggesting that IL-31 may represent a novel target for antipruritic drug development. |
|||
IL-31 Antibody |
|||
3745-01mg | ProSci | 0.1 mg | 436.42 EUR |
Description: IL-31 Antibody: Interleukin-31 (IL-31) is a recently discovered T-cell cytokine closely related to IL-6 type cytokines and is preferentially produced by T helper type 2 cells. IL-31 activity is mediated through the ligand-induced oligomerization of a dimeric receptor complex containing IL-31 receptor A and oncostatin M receptor. In response to IL-31 binding, these proteins activate the JAK/STAT and the AKT signaling pathways. RNA levels of IL-31 receptor A and oncostatin M receptor are induced in activated monocytes but are expressed constitutively in epithelial cells. IL-31, when overexpressed in transgenic mice, results in the development of pruritis, alopecia, and skin lesions and in humans may result in atopic dermatitis, suggesting that IL-31 may represent a novel target for antipruritic drug development. |
|||
IL-31 Antibody |
|||
3747-002mg | ProSci | 0.02 mg | 171.82 EUR |
Description: IL-31 Antibody: Interleukin-31 (IL-31) is a recently discovered T-cell cytokine closely related to IL-6 type cytokines and is preferentially produced by T helper type 2 cells. IL-31 activity is mediated through the ligand-induced oligomerization of a dimeric receptor complex containing IL-31 receptor A and oncostatin M receptor. In response to IL-31 binding, these proteins activate the JAK/STAT and the AKT signaling pathways. RNA levels of IL-31 receptor A and oncostatin M receptor are induced in activated monocytes but are expressed constitutively in epithelial cells. IL-31, when overexpressed in transgenic mice, results in the development of pruritis, alopecia, and skin lesions and in humans may result in atopic dermatitis, suggesting that IL-31 may represent a novel target for antipruritic drug development. |
|||
IL-31 Antibody |
|||
3747-01mg | ProSci | 0.1 mg | 436.42 EUR |
Description: IL-31 Antibody: Interleukin-31 (IL-31) is a recently discovered T-cell cytokine closely related to IL-6 type cytokines and is preferentially produced by T helper type 2 cells. IL-31 activity is mediated through the ligand-induced oligomerization of a dimeric receptor complex containing IL-31 receptor A and oncostatin M receptor. In response to IL-31 binding, these proteins activate the JAK/STAT and the AKT signaling pathways. RNA levels of IL-31 receptor A and oncostatin M receptor are induced in activated monocytes but are expressed constitutively in epithelial cells. IL-31, when overexpressed in transgenic mice, results in the development of pruritis, alopecia, and skin lesions and in humans may result in atopic dermatitis, suggesting that IL-31 may represent a novel target for antipruritic drug development. |
|||
AXMIR-31 RNA oligo anti-miRNA-31-5p with Xmotif |
|||
AXMIR-31 | SBI | 10 reactions | 438 EUR |
IL-31 |
|||
E21-053 | EnoGene | 10ug | 343 EUR |
Rabbit IL-31 ELISA Kit |
|||
ERTI0041 | Abclonal | 96Tests | 521 EUR |
Anti-IL-31 Antibody |
|||
A08339-1 | BosterBio | 100ug/vial | 334 EUR |
Anti-IL-31 antibody |
|||
STJ98951 | St John's Laboratory | 200 µl | 197 EUR |
Description: Rabbit polyclonal to IL-31. |
|||
IL-31, Interleukin-31, human |
|||
RC212-42 | Bio Basic | 2ug | 104.38 EUR |
Canine Interleukin 31(IL-31) |
|||
QY-E70194 | Qayee Biotechnology | 96T | 426 EUR |
IL-31, Human |
|||
HY-P7217 | MedChemExpress | 50ug | 762 EUR |
IL-31 Peptide |
|||
3745P | ProSci | 0.05 mg | 164.75 EUR |
Description: (NT) IL-31 peptide |
|||
IL-31 Peptide |
|||
3747P | ProSci | 0.05 mg | 164.75 EUR |
Description: (IN) IL-31 peptide |
|||
XMIRXpress lentivector miRNA-31-5p with Xmotif |
|||
XMIRXP-31 | SBI | 10 ug | 677 EUR |
Recombinant Human Interleukin-31/IL-31 |
|||
C053-10ug | Novoprotein | 10ug | 202 EUR |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4. |
|||
Recombinant Human Interleukin-31/IL-31 |
|||
C053-1mg | Novoprotein | 1mg | 3145 EUR |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4. |
|||
Recombinant Human Interleukin-31/IL-31 |
|||
C053-500ug | Novoprotein | 500ug | 2217 EUR |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4. |
|||
Recombinant Human Interleukin-31/IL-31 |
|||
C053-50ug | Novoprotein | 50ug | 496 EUR |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4. |
|||
Anti-human IL-31 antibody |
|||
STJ15100124 | St John's Laboratory | 500 µg | 527 EUR |
Description: This monoclonal antibody is recommended for neutralization of human IL-31 bioactivity. |
|||
Anti-human IL-31 antibody |
|||
STJ15100125 | St John's Laboratory | 250 µg | 336 EUR |
Description: These monoclonal antibodies enable sensitive and specific detection of human IL-31 in immunoassays such as ELISA and ELISpot. |
|||
Anti-human IL-31 antibody |
|||
STJ15100126 | St John's Laboratory | 250 µg | 367 EUR |
Description: This monoclonal antibody enables sensitive and specific detection of human IL-31 in immunoassays such as ELISA and ELISpot. |
|||
Anti-IL-31 alpha antibody |
|||
STJ96456 | St John's Laboratory | 200 µl | 197 EUR |
Description: Rabbit polyclonal to IL-31Ralpha. |
IL-31 Rabbit Polyclonal Antibody